lmmunohistochemical demonstration of metallothionein in benign and malignant canine mammary tumours by Fuentealba, Carmen & Mullins, J. E.
Histol Histopathol (1 999) 14: 51 -61 
http://www.ehu.es/histoI-histopathol 
Histology and 
Histopathology 
lmmunohistochemical demonstration of metallothionein 
in benign and malignant canine mammary tumours 
I.C. Fuentealba and J.E. Mullins 
Department of Pathology and Microbiology, Atlantic Veterinary College, 
University of Prince Edward Island, Charlottetown, Prince Edward Island, Canada 
Summary. Immunocytochemical demonstration of 
metallothionein (MT) has been reported as a useful 
prognostic tool in human breast cancer. The aim of this 
study was to determine the immunohistochemical 
location of MT in canine mammary tumours and its 
possible correlation with the morphologic characteristics 
of these tumours. Surgical specimens from spontaneous 
malignant (n=20) and benign mammary neoplasms 
(n=20) were processed for routine histological 
examination and immunohistochemical study. An 
indirect immunoperoxidase technique, using monoclonal 
antibody E9 against horse MT was employed. Intensity 
of the stain, the percentage of immunoreactive tumour 
cells and immunohistochemical overexpression of MT 
was estimated for each case. Metallothionein over- 
expression, defined as those cases with more than 10% 
immunopositive cells, was detected in both benign and 
malignant mammary tumours. However, strong immuno- 
staining intensity was seen in benign tumours, whereas 
in malignant tumours immunopositive cells stained 
weakly. Positive MT immunostaining occurred in 
neoplastic epithelial cells, and some chondrocytes 
present in mixed mammary tumours. I-Iowever, staining 
intensity was variable in immunopositive cells.  
Differences in staining intensity between the primary 
malignant mammary tumour, tumour emboli and 
metastatic cells within a lymph node were also noted. 
Myoepithelial cells and connective tissue did not stain 
for MT. We concluded that metallothionein immuno- 
staining cannot be used as a diagnostic or prognostic tool 
in canine mammary neoplasms. However, results of this 
study support the hypothesis that MT has a role in 
tumour proliferation and tumour progression. 
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Introduction 
Mammary tumours have been recognized as the 
second most common tumours in dogs (Hampe and 
Misdorp, 1974; Moulton, 1990; Destexhe et al., 1993). 
Classification of mammary tumours is mostly based on 
standard histopathology (Fowler et al., 1974) and 
although the prognosis is dependent on microscopic 
examination of submitted biopsies, classification of 
mammary neoplasms remains subjective and often 
confusing. Difficulties in establishing a uniform 
nomenclature are partially due to the diverse criteria 
which can be applied to classify these tumours. Canine 
mammary tumours have different proportions of 
epithelial,  myoepithelial,  and connective tissue 
components. In addition to the diverse histogenesis, the 
pattern of arrangement of neoplastic cells can also vary 
from papillary, tubular, cystic to medusoid, and the 
proportion of fibrous connective tissue stroma may be 
minimal or prominent such as in scirrhous carcinomas. 
An important criterion to classify a neoplasm should be 
the presence or absence of malignant behaviour, as 
evidenced by infiltration of adjacent tissues andfor 
lymphatic and blood vessel invasions. It is estimated that 
approximately 60% of canine mammary tumours are 
benign (Hampe and Misdorp, 1974; Moulton, 1990), but 
some neoplasms originally thought to be benign 
microscopically, ultimately become malignant and 
metastize throughout the body (Misdorp et al., 1971). 
Conversely, other mammary tumours appear malignant 
morphologically yet are benign in behaviour (Hampe 
and Misdor, 1974; Brealy, 1989). 
Research on metallothionein (MT), a metal-binding 
protein, has been traditionally focused on its role in 
metal homeostasis and toxicity (Hamer, 1986). In recent 
years, the role of MT in carcinogenesis (Cherian, 1994) 
and its potential applications differentiating aggressively 
malignant from benign neoplasms, has received 
increased attention. MT has been found to be elevated in 
ovarian neoplastic cells (Murphy et al., 1991) and its 
over expression in some cancer cell lines has been found 
to confer resistance to chemotherapy (Beck et al., 1979; 










